THC Farmaceuticals, Inc.
CBDG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$320.93K
Close$
$-0.01
136.2% downside
Current Fair Value
136.2% downsideOvervalued by 136.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $320,929.00 |
|---|---|
| Enterprise Value | $700,357.00 |
| Earnings per Share | $0 |
| Beta | -9.07 |
| Outstanding Shares | 18,131,600 |
Return
| Return on Equity | 1.73% |
|---|---|
| Return on Assets | 1.73% |
| Return on Invested Capital | 4.39% |
Valuation & Multiples
| P/E Ratio | -30.87 |
|---|---|
| PEG | 29.27 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 46.61 |
| Enterprise Value to EBIT | 7.29 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About THC Farmaceuticals, Inc.
2 employees
CEO: Mark D. Grossman
THC Farmaceuticals, Inc. specializes in the ownership and operation of independent (non-bank) automated teller machines (ATMs), strategically placing them within third-party retail and commercial establishments. These cash-dispensing uni...